ICAD - アイキャド (icad inc.) アイキャド

 ICADのチャート


 ICADの企業情報

symbol ICAD
会社名 iCAD inc (アイキャド)
分野(sector) Health Care   ヘルスケア
産業(industry) Medical/Dental Instruments  
業種 コンピュ―タ―ハ―ドウェア   医療関連(Health Care)
概要 事業概要 アイ・シーエーディー(iCAD Inc.)は高度な画像解析とワークフローソリューションの提供を行い、医療従事者に対して、患者において高頻度に見られるがんの早期特定と病理の早期識別を可能にする。同社はマンモグラフィー、磁気共鳴イメージング(MRI)やコンピュータ断層撮影(CT)を対象に一連のアップグレード可能なコンピュータ支援検出(CAD)システムやワークフローソリューションを提供する。同社のソリューションは放射線科医に対して、患者において高頻度に見られるがんの特定と病理の識別を可能にする。同社のデジタル及びMRI CAD製品は乳房撮影(マンモグラフィー)、乳房および前立腺のMRI画像診断、及びCTコロノグラフィー用の高度な画像解析とワークフローソリューションを含む。同社のフィルムベースの製品はマンモグラフィ・フィルムをデジタル画像に変換する製品を含む。同社の電子ブラキセラピー製品は乳がん治療用の電子ブラキセラピー(Ebx)療法を含む。   アイキャドは、米国の画像診断システム販売会社。癌の早期発見と治療のために、画像解析、ワ―クフロ―ソリュ―ションと放射線療法を提供する。マンモグラフィ用コンピュ―タ支援検出(CAD)ソリュ―ションを販売。また、結腸ポリ―プを検出する仮想大腸内視鏡検査やCTコロノグラフィ―(CTC)で使用するためのCADソリュ―ションを開発する。   iCAD Inc., headquartered in Nashua, New Hampshire, is a medical-device manufacturer. iCAD makes cancer detection and radiation therapy devices. iCAD offers computer aided detection and workflow solutions to support detection of breast, prostate and colorectal cancers.
本社所在地 98 Spit Brook Road Suite 100 Nashua NH 03062 USA
代表者氏名 Lawrence Howard ローレンスハワード
代表者役職名 Chairman of the Board 取締役会会長
電話番号 +1 603-882-5200
設立年月日 30713
市場名 NASDAQ Small Cap
ipoyear ―年
従業員数 119人
url www.icadmed.com
nasdaq_url https://www.nasdaq.com/symbol/icad
adr_tso
EBITDA EBITDA(百万ドル) -7.46900
終値(lastsale) 3.115
時価総額(marketcap) 52527425.755
時価総額 時価総額(百万ドル) 52.27448
売上高 売上高(百万ドル) 27.37700
企業価値(EV) 企業価値(EV)(百万ドル) 50.55348
当期純利益 当期純利益(百万ドル) 3.62400
決算概要 決算概要 BRIEF: For the six months ended 30 June 2018 iCAD Inc revenues decreased 5% to $12.5M. Net loss increased 40% to $4.3M. Revenues reflect a decrease in demand for the Company's products and services due to unfavorable market conditions. Higher net loss reflects Detection segment income decrease of 22% to $1M. Basic Earnings per Share excluding Extraordinary Items decreased from -$0.19 to -$0.26.

 ICADのテクニカル分析


 ICADのニュース

   Breast Cancer Brachytherapy Market is Slated to Witness Tremendous Growth | By Prominent Players -Elekta AB, Eckert & Ziegler BEBIG, Cianna Medical, ICAD Inc, Hologic Inc  2021/09/07 13:14:45 OpenPR
Increased use of breast HDR brachytherapy in hospitals and cancer treatment centers is also likely to drive segment growth. Furthermore, supportive actions by businesses and non-profit groups aimed at improving people''s lives are projected to enhance the industry. Breast cancer''s
   Global Intraoperative Radiation Therapy Market To Reflect Impressive Growth Rate by 2028||Players-IntraOp Medical, Inc., Ariane Medical Systems Ltd, Varian Medical Systems, Inc., Carl Zeiss AG, Eckert & Ziegler, Sensus Healthcare, iCAD Inc  2021/09/07 09:15:22 OpenPR
This Intraoperative Radiation Therapy report provides complete analysis of the market on global and regional level. It inspects the development rate and the market value dependent on the market elements and growth initiating factors. The market
   icad Inc hosts conference call for investors  2021/07/28 12:54:49 Business Insider Markets
The company, icad Inc, is set to host investors and clients on a conference call on 8/5/2021 5:21:28 PM. The call comes after the company''s earnings, which are set to be announced on 8/5/2021.Investors, or members of the public who wish to dial in, can join the call by visiting
   ICADE finalise 2 opérations tertiaires significatives  2021/07/06 09:52:00 Capital Fr
   ICADE (FR0000035081) : ICADE SANTE ACQUIERT 4 NOUVEAUX ETABLISSEMENTS EN FRANCE  2021/06/23 16:00:00 Les Echos Company News
   Breast Cancer Brachytherapy Market is Slated to Witness Tremendous Growth | By Prominent Players -Elekta AB, Eckert & Ziegler BEBIG, Cianna Medical, ICAD Inc, Hologic Inc  2021/09/07 13:14:45 OpenPR
Increased use of breast HDR brachytherapy in hospitals and cancer treatment centers is also likely to drive segment growth. Furthermore, supportive actions by businesses and non-profit groups aimed at improving people''s lives are projected to enhance the industry. Breast cancer''s
   Global Intraoperative Radiation Therapy Market To Reflect Impressive Growth Rate by 2028||Players-IntraOp Medical, Inc., Ariane Medical Systems Ltd, Varian Medical Systems, Inc., Carl Zeiss AG, Eckert & Ziegler, Sensus Healthcare, iCAD Inc  2021/09/07 09:15:22 OpenPR
This Intraoperative Radiation Therapy report provides complete analysis of the market on global and regional level. It inspects the development rate and the market value dependent on the market elements and growth initiating factors. The market
   icad Inc hosts conference call for investors  2021/07/28 12:54:49 Business Insider Markets
The company, icad Inc, is set to host investors and clients on a conference call on 8/5/2021 5:21:28 PM. The call comes after the company''s earnings, which are set to be announced on 8/5/2021.Investors, or members of the public who wish to dial in, can join the call by visiting
   ICADE finalise 2 opérations tertiaires significatives  2021/07/06 09:52:00 Capital Fr
   ICADE (FR0000035081) : ICADE SANTE ACQUIERT 4 NOUVEAUX ETABLISSEMENTS EN FRANCE  2021/06/23 16:00:00 Les Echos Company News
   ICAD Focuses On Areas Of High Unmet Need In Cancer Detection, BTIG Says  2021/03/23 18:39:39 Benzinga
ICAD Inc (NASDAQ: ICAD ) is poised to benefit in the long term from its AI-driven cancer detection tools and electronic brachytherapy product, according to BTIG. The iCAD Analyst: Marie Thibault initiated coverage of iCAD with a Buy rating and a price target of $25. The iCAD Thesis: The company’s two business segments — ProFound AI and Xoft eBx — are focused on “expanding into areas of high unmet need,” Thibault said in the initiation note. ICAD was the first to market an AI-powered detection solution … Full story available on Benzinga.com
   Icade’s (CDMGF) Hold Rating Reaffirmed at Deutsche Bank Aktiengesellschaft  2020/10/24 11:31:04 Dakota Financial News
Deutsche Bank Aktiengesellschaft reissued their hold rating on shares of Icade (OTCMKTS:CDMGF) in a research note issued to investors on Friday, The Fly reports. Other equities research analysts have also recently issued research reports about the stock. Bank of America raised shares of Icade from a neutral rating to a buy rating in a research […]
   Icade (OTCMKTS:CDMGF) Raised to Buy at Bank of America  2020/10/22 07:28:47 Dakota Financial News
Icade (OTCMKTS:CDMGF) was upgraded by equities research analysts at Bank of America from a “neutral” rating to a “buy” rating in a report issued on Tuesday, The Fly reports. Several other analysts have also recently commented on the stock. Morgan Stanley reiterated an “equal weight” rating on shares of Icade in a research report on […]
   Icade (OTCMKTS:CDMGF) Upgraded to “Buy” by Bank of America  2020/10/21 01:20:51 Daily Political
Bank of America upgraded shares of Icade (OTCMKTS:CDMGF) from a neutral rating to a buy rating in a research note published on Tuesday morning, The Fly reports. CDMGF has been the subject of a number of other research reports. Deutsche Bank Aktiengesellschaft reiterated a hold rating on shares of Icade in a research report on […]
   Icade : Credit ratings reaffirmed by Standard & Poor's - BBB+ with a stable outlook | MarketScreener  2020/07/24 06:41:08 MarketScreener
Credit ratings reaffirmed by Standard & Poor's - BBB+ with a stable outlook 24 Jul 2020 07:30 CEST … | July 24, 2020

 関連キーワード  (コンピュ―タ―ハ―ドウェア 米国株 アイキャド ICAD icad inc.)

 twitter  (公式ツイッターやCEOツイッターなど)